We are live on ! Find out more
OACCU

Oaktree Acquisition Corp III Life Sciences Unit
OACCU

6 hedge funds and large institutions have $9.07M invested in Oaktree Acquisition Corp III Life Sciences Unit in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding

Funds holding: 5 → 6 (+1)

1% more capital invested

Capital invested by funds: $9.02M → $9.07M (+$54.9K)

0.25% more ownership

Funds ownership: 4.7% → 4.95% (+0.25%)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DAM
DLD Asset Management
New York
+$477K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
ADAR1 Capital Management
Texas
$5.5M – – –
AAA
2
Affinity Asset Advisors
New York
$2.66M – – –
AC
3
Athos Capital
Hong Kong
$534K – – –
CS
4
Clear Street
New York
$236K – – –
UBS Group
5
UBS Group
Switzerland
$104K – – –
DAM
6
DLD Asset Management
New York
$33.4K +$477K +44,519 New

OACCU Hedge Fund Activity: Q1 2026 in Review

6 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Unit (OACCU) for Q1 2026, worth a combined $9.07M — up 0.61% from $9.02M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new OACCU positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was DLD Asset Management, opening a new position worth an estimated $477K.

  • 6 institutional investors held Oaktree Acquisition Corp III Life Sciences Unit (OACCU) as of Q1 2026, up from 5 in Q4 2025.
  • Funds reported $9.07M of Oaktree Acquisition Corp III Life Sciences Unit stock for Q1 2026, up 0.61% quarter-over-quarter.
  • 1 fund opened new Oaktree Acquisition Corp III Life Sciences Unit positions in Q1 2026 and 0 closed out, a net change of +1 holder.
  • The largest Oaktree Acquisition Corp III Life Sciences Unit buyer in Q1 2026 was DLD Asset Management, an estimated $477K added.

Based on aggregated 13F filings for Q1 2026.